Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies - Concepedia

Concepedia

Publication | Open Access

Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies

DOI Full Paper Access

112

Citations

23

References

2016

Year

Omoniyi J. Adedokun, Zhenhua Xu, Colleen Marano, Hongyan Zhang, Jewel Johanns, Honghui Zhou, Hugh M. Davis, Walter Reinisch, Brian G. Feagan, Paul Rutgeerts,

Journal of Crohn s and Colitis

Abstract

SGCs are approximately dose proportional, and a positive SGC-efficacy relationship exists during induction/maintenance golimumab treatment of adult UC patients. Optimal SGC targets require validation in prospective studies.

References

	Year	Citations

Page 1